# OnCo record paper-hayashi-site-specific-vs-empirical-chemotherapy-cup-jco-2019 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-hayashi-site-specific-vs-empirical-chemotherapy-cup-jco-2019/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-hayashi-site-specific-vs-empirical-chemotherapy-cup-jco-2019" ;
  schema:name "Randomised phase 2 trial of site-specific treatment based on gene expression profiling versus carboplatin and paclitaxel in cancer of unknown primary"@en ;
  schema:description "Using a gene expression test to guess where a cancer of unknown primary came from, and treating it as that cancer, did not help patients live longer than standard carboplatin and paclitaxel."@en ;
  schema:url <https://onco.cc/key-papers/paper-hayashi-site-specific-vs-empirical-chemotherapy-cup-jco-2019/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.18.00771>, <https://pubmed.ncbi.nlm.nih.gov/30653423/> ;
  schema:sameAs <https://doi.org/10.1200/JCO.18.00771> ;
  schema:datePublished "2019"^^xsd:gYear ;
  schema:author "Hayashi H, Kurata T, Takiguchi Y, et al." ;
  onco:cancers <https://onco.cc/cancers/cup-favourable-subsets/>, <https://onco.cc/cancers/cup-unfavourable/> ;
  onco:drugs <https://onco.cc/drugs/carboplatin/>, <https://onco.cc/drugs/paclitaxel/> ;
  onco:journals <https://onco.cc/journals/jco/> .